跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 23,982 条关于
“T-lymphoblastic lymphoma”
全部
23,982
临床试验
15,082
药物
3,571
机构
108
资讯
5,221
5个月前
Low-Dose CD7 CAR-T Cell Therapy Shows 93.5% Response Rate in Relapsed T-Cell Lymphomas
7个月前
FDA Approves Larger Vial Size of Nelarabine Injection for T-Cell Leukemia and Lymphoma Treatment
2年前
FDA Accepts NDA for SH-105, a Ready-to-Dilute Formulation for Breast and Ovarian Cancer
去年
Wugen Secures $115 Million to Advance First-in-Class Off-the-Shelf CAR-T Therapy for T-Cell Malignancies
2年前
WU-CART-007 Shows Promise in Relapsed/Refractory T-ALL/LBL
2个月前
Allotera Therapeutics Closes $35 Million Financing, Bringing Total to $150 Million for Pivotal-Stage Off-the-Shelf CAR-T Therapy in T-Cell Cancers
9个月前
Wugen's Allogeneic CAR-T Therapy Shows Promising Long-Term Survival Data in T-Cell Leukemia Patients
去年
Wugen Initiates Pivotal Trial of Novel Off-the-Shelf CAR-T Therapy for Rare Blood Cancers
去年
FDA Clears IND for Bioheng's Off-the-Shelf CAR-T Therapy CTD402 for T-Cell Leukemia/Lymphoma
去年
Universal CAR-T Cell Therapy Achieves 91% Response Rate in Aggressive T Cell Cancers
第 1 页,共 523 页
上一页
下一页